FAST NEWS: New Injectable Drug from Simcere Pharma Approved For Marketing In China
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced Wednesday it will market Cosela, a cyclin-dependent kinase CDK4/6 inhibitor developed by the group with G1 Therapeutics, in China after receiving conditional approval from the…
FAST NEWS: Innocare Pharma Loss Narrows on New Drug’s Contribution
The latest: Drug maker InnoCare Pharma Ltd. (9969.HK) announced Wednesday that its net loss shrank by 83.5% to 64.5 million yuan ($10.1 million) last year from 2020 levels. Looking up: The company…
FAST NEWS: MicroPort Scientific’s Shanghai Unit Posted Up to 50% Profit Growth Last Year
The latest: Medical device maker MicroPort Scientific Corp. (0853.HK) said late on Monday that its 46%-owned subsidiary, Shanghai MicroPort Endovascular MedTech (Group) Co. Ltd. (688016.CN), will record a 40% to…
RELATED ARTICLES
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK -
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
As solar construction in China cools, Hainan Drinda looks for relief overseas
002865.SHE
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Clinical trials come up short again for Alphamab Oncology
9966.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
Ascentage Pharma soars on deal with cancer drug competitor
6855.HK
